Clinical Trials Browser

Phase 3 × sugemalimab × Thoracic × Clear all

NCT06617416 2025-03-12

A Study of AK104 in Subjects With Unresectable Locally Advanced NSCLC

Phase 3 Recruiting

Carcinoma, Non-Small-Cell Lung